HLA-B27 determination using serological methods. A comparison of enzyme immunoassay and a microlymphocytotoxic test with flow cytometry and a molecular biological assay

Rheumatology International

Volumn 16, Issue 3, 1996, Pages 95-100

  Dunky, A ^a   Neumuller J ^b   Hubner C ^a   Fischer, G F ^c   Bayer, P M ^a   Wagner, E ^a   Schwartz, D W M ^c   Mayr, W R ^c  

^a WILHELMINEN HOSPITAL   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Enzyme immunoassay; Flow cytometry; HLA B27; Microlymphocytotoxicity test; Rheumatology

Indexed keywords

ANTIBODY; HLA B27 ANTIGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; ENZYME IMMUNOASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LABORATORY TEST; LYMPHOCYTOTOXICITY; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; PLASMA; PRIORITY JOURNAL; RELIABILITY; RHEUMATIC DISEASE; SAFETY; SEROLOGY; SERUM; SPONDYLARTHRITIS; VEIN PUNCTURE;

EID: 0029794683     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01409980     Document Type: Article

References (40)

1. Calin A (1989) Ankylosing spondylitis. In: Kelley WN, Harris ED Jr, Ruddy S, Sledge CB (eds) Textbook of rheumatology. Saunders, Philadelphia, pp 1021-1052
2. Brewerton DA, Caffrey M, Hart FD, James DCO, Nicholls A, Sturrock RD (1973) Ankylosing spondylitis and HLA-B27. Lancet I: 904-907
3. Schlosstein L, Terasaki PI, Bluestone R, Pearson CM (1973) High association of HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 288:704-706
4. Nickerson CL, Luthra HS, David CS (1990) Role of enterobacteria and HLA-B27 in spondyloarthropathies: studies with transgenic mice. Ann Rheum Dis 49:426-433
5. Gladman DD, Anhorn KAB, Schachter RK, Mervart H (1986) HLA antigens in psoriatic arthritis. J Rheumatol 13:586-592
6. Gladman DD, Brubacher B, Buskila D, Langevitz P, Farewell VT (1992) Psoriatic spondyloarthropathy in men and women: a clinical, radiographic, and HLA study. Clin Invest Med 15: 371-375
7. Kellner H, Yu D (1992) The pathogenetic aspects of spondyloarthropathies from the point of view of HLA-B27. Rheumatol Int 12:121-127
8. López de Castro JA (1994) Structure, function, and disease association of HLA-B27. Curr Opin Rheumatol 6:371-377
9. Brand DL, Ray JG Jr, Hare DB, Kayhoe DE, McClelland JD (1970) Preliminary trials toward standardization of leucocyte typing. In: Terasaki PI (ed) Histocompatibility testing 1970. Munksgaard, Copenhagen, pp 357-367
10. Albrecht J, Müller HAG (1987) HLA-B27 typing by use of flow cytofluorometry. Clin Chem 33:1619-1623
11. Janssen WCM, Rouwen JACN, Hoffmann JJML (1992) Improved flow cytometric method for HLA-B27 typing. Ann Clin Biochem 29:663-667
12. Ax W (1991) Das HLA System: B27 Typisierung mit Hilfe der Flow-Zytometric. Klin Lab 9:267
13. Orr K, Thomson GTD, Alfa M (1994) Utilization of commercial antisera and flow cytometry in HLA-B27 typing. Cytometry 18:17-20
14. Hulstaert F, Albrecht J, Hannet I, Lancaster P, Buchner L, Kunz J. Falkenrodt A, Tongio M, De Keyser F, Veys EM, Noens L, Mir N, Costello C, Becker R, Strauss K (1994) An optimized method for routine HLA-B27 screening using flow cytometry. Cytometry 18:21-29
15. Doxiadis I, Westhoff U, Grosse-Wilde H (1989) Quantification of soluble HLA class I gene products by an enzyme linked immunosorbent assay. Blut 59:449-454
16. Santoso S, Kiefel V, Volz H, Mueller-Eckhardt C (1992) Quantitation of soluble HLA class I antigen in human albumin and immunoglobulin preparations for intravenous use by solid-phase immunoassay. Vox Sang 62:29-33
17. Chang CH, Ferrone S, Pouletty P (1991) sHLA-STAT B27. An ELISA for HLA typing using serum. Hum Immunol 32 [Suppl 1]: 289
18. Huetz F, Lucotte G, Kahan A, Amor B (1987) Polymorphisme de restriction Taq I et allèle HLA B27 dans la spondylarthrite ankylosante. Rev Rhum 54:175-178
19. Ness DB, Grumet FC (1987) New polymorphisms of HLA-B27 and other B locus antigens detected by RFLP using a locus-specific probe. Hum Immunol 18:65-73
20. Steffens-Nakken HM, Zwart G, van den Bergh FAJTM (1995) Validation of allele-specific polymerase chain reaction for DNA typing of HLA-B27. Clin Chem 41:687-692
21. Olerup O (1994) HLA-B27 typing by group-specific PCR amplification. Tissue Antigens 43:253-256
22. Middleton D, Williams F, Cullen C, Mallon E (1995) Modification of an HLA-B PCR-SSOP typing system leading to improved allele determination. Tissue Antigens 45:232-236
23. López-Larrea C, Sujirachato K, Mehra NK, Chiewsilp P, Isarangkura D, Kanga U, Dominguez O, Coto E, Pena M, Seitén F, Gonzalez-Roces S (1995) HLA-B27 subtypes in Asian patients with ankylosing spondylitis. Tissue Antigens 45:169-176
24. Pouletty P, Chang C, Kalil J, Atwood E, Ferrone S, Shimizu B, Howson W, Mazaheri R, Del Villano B, Grumet C (1993) Typing of serum-soluble HLA-B27 antigen by ELISA. Tissue Antigens 42:14-19
25. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
26. Craxton M (1991) Linear amplification sequencing, a powerful method for sequencing. Methods: a companion to Methods Enzymol 3:20-26
27. Fischer GF, Faé I, Petrasek M, Haas H, Mayr WR (1995) An HLA-DR11 variant (HLA-DRB1*1115) segregating in a family of Turkish origin. Tissue Antigens 45:145-147
28. Neumüller J, Fischer M, Eberl R (1993) Failure of the serological determination of HLA-B27 due to antigen masking in patients with ankylosing spondylitis. Rheumatol Int 13:163-167
29. Krangel MS (1986) Secretion of HLA-A and -B antigens via an alternative RNA splicing pathway. J Exp Med 163:1173-1190
30. Krangel MS (1987) Two forms of HLA class I molecules in human plasma. Hum Immunol 20:155-165
31. Dobbe LME, Stam NJ, Neefjes JJ, Giphart MJ (1988) Biochemical complexitiy of serum HLA class I molecules. Immunogenetics 27:203-210
32. Grosse-Wilde H, Doxiadis I (1989) Allotyping for HLA class I using plasma as antigen source. J Immunogenet 16:149-155
33. Grumet FC, Buelow R, Grosse-Wilde H, Kubens B, Garovoy M, Pouletty P (1994) Report of the second international soluble HLA (sHLA) workshop. Hum Immunol 40:153-160
34. Zavazava N, Wobst B, Ferstl R, Müller-Ruchholtz W (1994) Soluble MHC class I molecules in human body fluids. J Clin Lab Anal 8:432-436
35. Ferronc S, Yamamura M, Grosse-Wilde H, Pouletty P (1992) W14.1 Summary of the serum-soluble HLA class I antigen component. In: Tsuji K, Aizawa M, Sasazuki T (eds) HLA 1991. Oxford University Press, Oxford, pp 1057-1061
36. Puppo F, Scudeletti M, Indiveri F, Ferrone S (1995) Serum HLA class I antigens: markers and modulators of an immune respone? Immunol Today 16:124-127
37. Tsuchiya N, Husby G, Williams RC Jr (1989) Studies of humoral and cell-mediated immunity to peptides shared by HLA-27.1 Klebsiella pneumoniae nitrogenase in ankylosing spondylitis. Clin Exp Immunol 76:354-360
38. Toubert A, Hamachi M, Raffoux C, Park MS, Yu DTY (1990) Epitope mapping of an HLA-B27 monoclonal antibody that also reacts with a 35-kD bacterial outer-membrane protein. Clin Exp Immunol 82:16-20
39. Groß U, Chen J-H, Kono DH, Yu DTY (1990) A ribosomal protein of Yersinia pseudotuberculosis having partial epitope identity with HLA-B27. Autoimmunity 7:267-277
40. Russo C, Fotino M, Carbonara A, Ferrone S (1987) A double determinant immunoassay for HLA class I typing using serum as an antigen source. Hum Immunol 19:69-77